Avidity Partners Management LP bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 169,000 shares of the company’s stock, valued at approximately $2,398,000. Avidity Partners Management LP owned about 0.18% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Wellington Management Group LLP grew its stake in shares of Acadia Healthcare by 11.8% in the third quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock worth $233,327,000 after acquiring an additional 993,205 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after acquiring an additional 681,278 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after acquiring an additional 3,815,471 shares in the last quarter. Abrams Bison Investments LLC grew its stake in shares of Acadia Healthcare by 22.3% in the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock worth $108,449,000 after acquiring an additional 800,000 shares in the last quarter. Finally, UBS Group AG grew its stake in shares of Acadia Healthcare by 8.8% in the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after acquiring an additional 350,484 shares in the last quarter.
Analyst Ratings Changes
Several research firms have commented on ACHC. Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Cantor Fitzgerald boosted their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. UBS Group boosted their price target on shares of Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a research note on Friday, April 17th. KeyCorp restated an “overweight” rating and issued a $30.00 price target on shares of Acadia Healthcare in a research note on Wednesday, May 27th. Finally, Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $26.85.
Acadia Healthcare Price Performance
Acadia Healthcare stock opened at $24.60 on Friday. The stock has a market cap of $2.26 billion, a P/E ratio of -2.01, a price-to-earnings-growth ratio of 8.20 and a beta of 0.69. The company has a fifty day simple moving average of $25.52 and a 200-day simple moving average of $20.04. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $30.20. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities analysts expect that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
